http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3658181-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f97a8ebb44988fc8523c46a32f1c00f
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-085
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-085
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-31
filingDate 2018-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06f95a370fc5a49a0039122318edb234
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c395feb4646dc17663938e6bb7821b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d75800d0a0f5bdc273564d561c7e28f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fcbda775e396dee5f4c62ee78932aa79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb197bccaf4c08a4fe742f40fecb87c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5d1ffa7e70ffd7263eca49ab93facf5
publicationDate 2020-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-3658181-A1
titleOfInvention Immunogenic composition comprising a fusion peptide derived from superantigen toxoids
abstract The present invention relates to immunogenic compositions useful for preventing and treating Staphylococcus aureus infection. The invention further relates to multivalent oligopeptides, fusion proteins comprising two or more staphylococcal superantigen (SAg) proteins, or any fragment, variant, derivative or mutant thereof fused together in the form of of a single polypeptide in any order.
priorityDate 2017-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441477
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54686786
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397242
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6433
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3034366
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398728
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1148
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406329
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6305
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45051774
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405558
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66601235
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5959
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405557
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439186
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395488
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6255
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420747
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54704426
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226491587
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395489
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226428616

Total number of triples: 52.